Home › Non-Muscle Invasive Bladder Cancer › Texas › Dallas
Non-Muscle Invasive Bladder Cancer clinical trials in Dallas, TX
10 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- Urology Clinics of North Texas, Dallas
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- and 2 more
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
RecruitingObservational study
- UT Southwestern Medical Center, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RecruitingPhase 2
- UT Southwestern Medical Center, Dallas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
RecruitingObservational study
- University of Texas Southwestern Medical Center, Dallas
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
RecruitingObservational study
- UT Southwestern Medical Center, Dallas
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
RecruitingPhase 1/2
- University of Texas Southwestern Medical Center, Dallas
Blue Light Cystoscopy With Cysview® Registry
RecruitingObservational study
- UT Southwestern, Dallas
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Nashville, TN8 studies
- Syracuse, NY8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Philadelphia, PA7 studies
- Birmingham, AL7 studies
- Atlanta, GA7 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.